KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Net Cash Flow (2016 - 2026)

Globus Medical filings provide 15 years of Net Cash Flow readings, the most recent being $150.4 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 9.4% to $150.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$280.7 million, a 188.59% decrease, with the full-year FY2025 number at -$280.7 million, down 188.59% from a year prior.
  • Net Cash Flow hit $150.4 million in Q4 2025 for Globus Medical, up from $141.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $208.3 million in Q3 2024 to a low of -$326.7 million in Q1 2025.
  • Median Net Cash Flow over the past 5 years was $44.7 million (2022), compared with a mean of $13.2 million.
  • The widest YoY moves for Net Cash Flow: up 7584.31% in 2021, down 1341.24% in 2021.
  • Globus Medical's Net Cash Flow stood at -$168.6 million in 2021, then surged by 110.13% to $17.1 million in 2022, then surged by 1000.68% to $188.0 million in 2023, then decreased by 11.74% to $166.0 million in 2024, then fell by 9.4% to $150.4 million in 2025.
  • The last three reported values for Net Cash Flow were $150.4 million (Q4 2025), $141.8 million (Q3 2025), and -$246.2 million (Q2 2025) per Business Quant data.